Evidence map›Paper›PMID 35766008›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2022

Upregulation of ribosome complexes at the blood-brain barrier in Alzheimer's disease patients.

Masayoshi Suzuki, Kenta Tezuka, Takumi Handa, Risa Sato, Hina Takeuchi, Masaki Takao, Mitsutoshi Tano, Yasuo Uchida

Open access · greenAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 73 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The multifaceted roles of ribosomal P complex in cancer.World journal of surgical oncology · 2025
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Masayoshi SuzukiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Kenta TezukaGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Takumi HandaGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Risa SatoGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Hina TakeuchiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Masaki TakaoDepartment of Neurology and Brain Bank, Mihara Memorial Hospital, Isesaki, Japan.
Mitsutoshi TanoDepartment of Neurology and Brain Bank, Mihara Memorial Hospital, Isesaki, Japan.
Yasuo UchidaGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.ORCID 0000-0001-9860-1979
Tohoku University · JPInstitute of Brain and Blood Vessels · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cerebrovascular-specific molecular mechanism in Alzheimer's disease (AD) was investigated by employing comprehensive and accurate quantitative proteomics. Highly purified brain capillaries were isolated from cerebral gray and white matter of four AD and three control donors, and examined by SWATH (sequential window acquisition of all theoretical fragment ion spectra) proteomics. Of the 29 ribosomal proteins that were quantified, 28 (RPLP0, RPL4, RPL6, RPL7A, RPL8, RPL10A, RPL11, RPL12, RPL14, RPL15, RPL18, RPL23, RPL27, RPL27A, RPL31, RPL35A, RPS2, RPS3, RPS3A, RPS4X, RPS7, RPS8, RPS14, RPS16, RPS20, RPS24, RPS25, and RPSA) were significantly upregulated in AD patients. This upregulation of ribosomal protein expression occurred only in brain capillaries and not in brain parenchyma. The protein expression of protein processing and N-glycosylation-related proteins in the endoplasmic reticulum (DDOST, STT3A, MOGS, GANAB, RPN1, RPN2, SEC61B, UGGT1, LMAN2, and SSR4) were also upregulated in AD brain capillaries and was correlated with the expression of ribosomal proteins. The findings reported herein indicate that the ribosome complex, the subsequent protein processing and N-glycosylation-related processes are significantly and specifically upregulated in the brain capillaries of AD patients.

Indexed as

Alzheimer DiseaseHexosyltransferasesBlood-Brain BarrierHumansProteasome Endopeptidase ComplexRibosomal ProteinsRibosomesUp-RegulationHexosyltransferasesProteasome Endopeptidase ComplexRibosomal ProteinsRPL7A protein, humanRPN2 protein, humanAlzheimer’s diseaseblood-brain barrierN-glycosylationprotein processingRibosome

Identifiers

PMID35766008
PMCPMC9580172
OpenAlexW4283718164

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.